IP Library Granted Patent US 12,201,422
Granted Patent B2
US 12,201,422 · App. 17/128,287 · Granted Jan 21, 2025

Methods of manufacture to optimize performance of transdermal sampling and analysis device

Inventors: Joseph J. Vidalis (Bethesda, MD); Joseph A. Marcanio (Greensburg, PA); John Frederick Currie (Bethesda, MD); Helena Woodvine Snyder (Washington, DC); Vikas Bhatia (Gaithersburg, MD)
Assignee: Cambridge Medical Technologies LLC
A61B5/150076A61B5/14532A61B5/1486A61B5/150022A61B5/150274A61B5/150862A61B5/15134A61B5/157
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,422
App. No.
17/128,287
Granted
Jan 21, 2025
Kind
B2
Abstract

Methods and systems for manufacturing a transdermal sampling and analysis device for non-invasively and transdermally obtaining biological samples from a subject and determining levels of analytes of the obtained biological samples are provided. A method of manufacturing the device may improve performance and includes forming channel structures on the lid of the device, thereby making the spacer/channel support structures physically independent and separable from the sensing electrode. Other methods of manufacturing the device may improve performance and include forming at least one of the electrodes on each of the base and the lid, and forming a recessed second spacer layer over the channel support structures, thereby separating the channel support structures and the electrode on the lid to allow a larger area of the electrode to be exposed to the biological sample.

Claims (36)

1. A method of making a transdermal sampling and analysis device adapted to be placed on skin, the method comprising:

forming a base structure with at least a first electrode and a plurality of channel support structures;

forming a lid structure configured to be positioned above the at least first electrode, wherein forming the lid structure comprises:

depositing a conductive material layer on a lid substrate to create a lid conductive material layer; and

patterning the lid conductive material layer to form at least a second electrode; and

attaching the lid structure to the base structure using an adhesive material on surfaces of the plurality of channel support structures,

wherein attaching the lid structure to the base structure forms a plurality of channels in a reservoir between the plurality of channel support structures,

wherein the reservoir comprises:

a circular collection portion configured to collect a biological sample obtained through permeable skin barrier cells, wherein the circular collection portion is substantially parallel to a plane of the skin; and

a sensing chamber portion configured to receive the biological sample from the circular collection portion, wherein the sensing chamber portion surrounds a periphery of the circular collection portion substantially parallel to the plane of the skin, wherein the at least first electrode and the at least second electrode are located proximate to the sensing chamber portion.

2. The method of claim 1 , wherein forming the base structure comprises:

depositing a conductive material layer on a base substrate to create a base conductive material layer;

patterning the base conductive material layer to form a disruptor, the at least first electrode, and interconnects;

applying a photoresist material to the base substrate;

patterning the photoresist material to form the plurality of channel support structures; and

depositing a layer of an analyte sensing reagent on surfaces of the at least first electrode.

3. The method of claim 1 , wherein forming the lid structure further comprises:

applying a layer of an analyte sensing reagent to surfaces of the at least second electrode; and

applying a photoresist material to the lid substrate.

4. The method of claim 1 , wherein the adhesive material is approximately 5-20 μm thick.

5. A method of making a transdermal sampling and analysis device, comprising:

forming a base structure with at least a first electrode;

forming a lid structure configured to be positioned above the at least first electrode, wherein the lid structure has a plurality of channel support structures; and

attaching the lid structure to the base structure using an adhesive material on surfaces of the plurality of channel support structures,

wherein attaching the lid structure to the base structure forms a plurality of channels in a reservoir between the plurality of channel support structures,

wherein the reservoir comprises:

a circular collection portion configured to collect a biological sample obtained through permeable skin barrier cells, wherein the circular collection portion is substantially parallel to a plane of the skin; and

a sensing chamber portion configured to receive the biological sample from the circular collection portion, wherein the sensing chamber portion surrounds a periphery of the circular collection portion substantially parallel to the plane of the skin, wherein the at least first electrode is located proximate to the sensing chamber portion.

6. The method of claim 5 , wherein forming the base structure comprises:

depositing a conductive material layer on a base substrate to create a first conductive material layer;

patterning the first conductive material layer to form a disruptor, the at least first electrode, and interconnects; and

depositing a layer of an analyte sensing reagent on surfaces of the at least first electrode.

7. The method of claim 5 , wherein forming the lid structure comprises:

applying a photoresist material to the lid substrate;

patterning the photoresist material to form the plurality of channel support structures; and

selectively applying the adhesive material to surfaces of the plurality of channel support structures, wherein each surface comprises an outward-facing surface that directly contacts the base structure.

Assignments (3)
CHANGE OF NAME Recorded Oct 29, 2024
From: CLINITECH, LLC
To: CAMBRIDGE MEDICAL TECHNOLOGIES LLC
Reel/Frame 069047/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2020
From: VIDALIS, JOSEPH J.; MARCANIO, JOSEPH A.; CURRIE, JOHN FREDERICK; SNYDER, HELENA WOODVINE; BHATIA, VIKAS
To: FLEXIBLE MEDICAL SYSTEMS LLC
Reel/Frame 054718/0793 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 22, 2020
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: CLINITECH, LLC
Reel/Frame 054719/0022 →
Continuity (3)
Division 14208344 · Mar 13, 2014
Provisional Application 61791970 · Mar 15, 2013
Related Publication 20210128036A1 · May 6, 2021
References Cited (151)
US 4197853A · Parker · 1980 [cited by applicant]
US 4526176A · Bremer et al. · 1985 [cited by applicant]
US 4775361A · Jacques et al. · 1988 [cited by applicant]
US 4821733A · Peck · 1989 [cited by applicant]
US 4909256A · Peck · 1990 [cited by applicant]
US 5019034A · Weaver et al. · 1991 [cited by applicant]
US 5123902A · Muller et al. · 1992 [cited by applicant]
US 5149629A · Rishpon et al. · 1992 [cited by applicant]
US 5176881A · Sepaniak et al. · 1993 [cited by applicant]
US 5203327A · Schoendorfer et al. · 1993 [cited by applicant]
US 5284748A · Mroczkowski et al. · 1994 [cited by applicant]
US 5330527A · Mroczkowski et al. · 1994 [cited by applicant]
US 5362307A · Montecalvo et al. · 1994 [cited by applicant]
US 5366454A · Currie et al. · 1994 [cited by applicant]
US 5380272A · Gross · 1995 [cited by applicant]
US 5458140A · Eppstein et al. · 1995 [cited by applicant]
US 5711861A · Ward et al. · 1998 [cited by applicant]
US 5722397A · Eppstein · 1998 [cited by applicant]
US 5730714A · Guy et al. · 1998 [cited by applicant]
US 5885211A · Eppstein et al. · 1999 [cited by applicant]
US 5983131A · Weaver et al. · 1999 [cited by applicant]
US 5985116A · Ikeda et al. · 1999 [cited by applicant]
US 6022316A · Eppstein et al. · 2000 [cited by applicant]
US 6046051A · Jina · 2000 [cited by applicant]
US 6056738A · Marchitto et al. · 2000 [cited by applicant]
US 6124597A · Shehada et al. · 2000 [cited by applicant]
US 6144869A · Berner et al. · 2000 [cited by applicant]
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 6233471B1 · Berner et al. · 2001 [cited by applicant]
US 6270651B1 · Essalik et al. · 2001 [cited by applicant]
US 6281006B1 · Heller et al. · 2001 [cited by applicant]
US 6342037B1 · Roe et al. · 2002 [cited by applicant]
US 6393318B1 · Conn et al. · 2002 [cited by applicant]
US 6436078B1 · Svedman · 2002 [cited by applicant]
US 6464687B1 · Ishikawa et al. · 2002 [cited by applicant]
US 6572542B1 · Houben et al. · 2003 [cited by applicant]
US 6597946B2 · Avrahami et al. · 2003 [cited by applicant]
US 6730200B1 · Stewart et al. · 2004 [cited by applicant]
US 6887202B2 · Currie et al. · 2005 [cited by applicant]
US 6922586B2 · Davies · 2005 [cited by applicant]
US 7001495B2 · Thomas · 2006 [cited by applicant]
US 7223364B1 · Johnston et al. · 2007 [cited by applicant]
US 7287318B2 · Bhullar et al. · 2007 [cited by applicant]
US 7826981B2 · Goode, Jr. et al. · 2010 [cited by applicant]
US 8173380B2 · Yang et al. · 2012 [cited by applicant]
US 8333874B2 · Currie · 2012 [cited by applicant]
US 8364228B2 · Currie et al. · 2013 [cited by applicant]
US 9877673B2 · Currie et al. · 2018 [cited by applicant]
US 9968284B2 · Vidalis et al. · 2018 [cited by applicant]
US 10376146B2 · Mujeeb-U-Rahman et al. · 2019 [cited by applicant]
US 20010052459A1 · Essalik et al. · 2001 [cited by applicant]
US 20020051975A1 · Li et al. · 2002 [cited by applicant]
US 20020055704A1 · Scott et al. · 2002 [cited by applicant]
US 20020086436A1 · Buechler · 2002 [cited by applicant]
US 20020169394A1 · Eppstein et al. · 2002 [cited by applicant]
US 20030003524A1 · Taniike · 2003 [cited by examiner]
US 20030100040A1 · Bonnecaze et al. · 2003 [cited by applicant]
US 20030100846A1 · Custer et al. · 2003 [cited by applicant]
US 20030130616A1 · Steil et al. · 2003 [cited by applicant]
US 20030208152A1 · Avrahami et al. · 2003 [cited by applicant]
US 20030214304A1 · Karinka et al. · 2003 [cited by applicant]
US 20030225362A1 · Currie et al. · 2003 [cited by applicant]
US 20040039343A1 · Eppstein et al. · 2004 [cited by applicant]
US 20040058172A1 · Summers et al. · 2004 [cited by applicant]
US 20040157319A1 · Keen · 2004 [cited by applicant]
US 20040180391A1 · Gratzl et al. · 2004 [cited by applicant]
US 20040193219A1 · Asano et al. · 2004 [cited by applicant]
US 20040217018A1 · Leong et al. · 2004 [cited by applicant]
US 20040224369A1 · Cai et al. · 2004 [cited by applicant]
US 20040253304A1 · Gross et al. · 2004 [cited by applicant]
US 20050042766A1 · Ohman et al. · 2005 [cited by applicant]
US 20050045476A1 · Neel et al. · 2005 [cited by applicant]
US 20050069454A1 · Bell · 2005 [cited by applicant]
US 20050175505A1 · Cantor et al. · 2005 [cited by applicant]
US 20050182307A1 · Currie et al. · 2005 [cited by applicant]
US 20050226921A1 · Kortzebom · 2005 [cited by applicant]
US 20050228340A1 · Cleary et al. · 2005 [cited by applicant]
US 20060076236A1 · Shah · 2006 [cited by examiner]
US 20060241514A1 · Davies · 2006 [cited by applicant]
US 20060285996A1 · Ohman et al. · 2006 [cited by applicant]
US 20090099434A1 · Liu et al. · 2009 [cited by applicant]
US 20090281404A1 · Currie et al. · 2009 [cited by applicant]
US 20090308742A1 · Paranjape · 2009 [cited by applicant]
US 20100160755A1 · Oviatt et al. · 2010 [cited by applicant]
US 20100319436A1 · Sun · 2010 [cited by examiner]
US 20120073986A1 · Jackson et al. · 2012 [cited by applicant]
US 20120150004A1 · Currie · 2012 [cited by examiner]
US 20120181189A1 · Merchant · 2012 [cited by applicant]
US 20120187000A1 · Kahn et al. · 2012 [cited by applicant]
US 20120245445A1 · Black et al. · 2012 [cited by applicant]
US 20120283539A1 · Freeman et al. · 2012 [cited by applicant]
US 20130131478A1 · Simpson et al. · 2013 [cited by applicant]
US 20130144142A1 · Vidalis et al. · 2013 [cited by applicant]
US 20140135679A1 · Mann et al. · 2014 [cited by applicant]
US 20140275895A1 · Vidalis et al. · 2014 [cited by applicant]
US 20150065818A1 · Say et al. · 2015 [cited by applicant]
US 20150140584A1 · Wilsey · 2015 [cited by applicant]
US 20160135721A1 · Bollmann et al. · 2016 [cited by applicant]
US 20170325724A1 · Wang et al. · 2017 [cited by applicant]
US 20180128766A1 · Cardosi et al. · 2018 [cited by applicant]
US 20180338713A1 · Polsky et al. · 2018 [cited by applicant]
US 20180353748A1 · Heikenfeld et al. · 2018 [cited by applicant]
US 20190076075A1 · Miller et al. · 2019 [cited by applicant]
US 20190216374A1 · Hoss et al. · 2019 [cited by applicant]
EP 1003033A1 · 2000 [cited by applicant]
KR 1020060082852A · 2006 [cited by applicant]
WO 9719344A1 · 1997 [cited by applicant]
WO 9956613A1 · 1999 [cited by applicant]
WO 2006050032A2 · 2006 [cited by applicant]
WO 2006063063A2 · 2006 [cited by applicant]
WO 2007070093A2 · 2007 [cited by applicant]
WO 9742882A1 · 2007 [cited by applicant]
WO 2009042631A2 · 2009 [cited by applicant]
WO 2011053715A2 · 2011 [cited by applicant]
WO 2014149514A1 · 2014 [cited by applicant]
WO 2018237259A1 · 2018 [cited by applicant]
International Search Report with Written Opinion cited in related Patent Application No. PCT/US2011/06558, 15 pages, issued Jul. 25, 2012, (Jul. 27, 2012). [cited by applicant]
International Search Report and Written Opinion cited in related Patent Application No. PCT/US05/44287, 5 pages, (Aug. 28, 2006). [cited by applicant]
International Preliminary Examination Report cited in related Patent Application No. PCT/US01/17081, 5 pages, (Sep. 17, 2004). [cited by applicant]
Henderson et al., “Excretion of Methadone and Metabolites in Human Sweat,” Research Communications in Chemical Pathology and pharmacology, vol. 5, No. 1, pp. 1-8, (Jan. 1973). [cited by applicant]
Peck et al., “Outward Transcutaneous Chemical Migration: Impliations for Diagnostics and Dosimetry”, Skin Pharmacol., vol. 1, No. I, pp. 14-23, (1988). [cited by applicant]
Phillips et al., “A Sweat-Patch Test for Alcohol Consumption: Evaluation in Continuous and Episodic Drinkers”, Alcohol: clinical and Experimental research, vol. 4, No. 4, pp. 391-395,(1980). [cited by applicant]
“SpectRx an Innovactive Medical Technology Company” [online], Copyright 2004, 1 p., Retrieved from the Internet: hhtp://www.spectrx.com. (Aug. 31, 2004). [cited by applicant]
Schneider et al., “B-Fit System: Bio-Flips Integrable Transdermal MicroSystem”, ARO Workshop on Biomolecular Signaling, Energy Transfer, and Transduction Processes, Cashiers, NC, 16 pages, (May 14-17, 2000). [cited by applicant]
Smith et al., “Cocaine in Hair, Saliva, Skin Swabs, and Urine of Cocaine Users' Children”, Forensic Science International, vol. 83, pp. 179-189, (1996). [cited by applicant]
Currie et al., “Novel Non-Intrusive Trans-Dermal Remote Wireless Micro-Fluidic Monitoring System Applied to Continuous Glucose and Lactate Assays for Casualty Care and Combat Readiness,” NATO: RTO-MP-HFM-109, pp. 24-1-2… [cited by applicant]
Nijdam, A.J., et al., “Fluidic encapsulation in SU-8 [micro]-reservoirs with [micro]-fluidic through-chip channels”, Sensors and Actuators A, vol. 120, p. 172-183; (Apr. 29, 2005). [cited by applicant]
Gadre et al., “Fabrication of a fluid encapsulated dermal patch using multilayered SU-8,” Sensors and Actuators A: Physical, 114(2-3):478-485 (2004). [cited by applicant]
Paranjape et al., “A PDMS dermal patch for non-intrusive transdermal glucose sensing,” Sensors and Actuators A: Physical, 104(3):195-204 (2003). [cited by applicant]
European Search Report dated Apr. 29, 2009, issued in US Application No. PCT/US2006023194, (May 13, 2009). [cited by applicant]
Xu, “Electrochemical Detection Optimized for Capillary Liquid Chromatographic Determination of Neuroactive Compounds”, University of Pittsburgh, 137 pages, (Nov. 10, 2011). [cited by applicant]
Boder, et al., “Development of Monoclonal Antibodies for an Assay of Cardiac Tropinin-I and Preliminary Results in Suspected Cases of Myocardial Infarction”, Clin. Chem. 38/11, pp. 2203-2214, (1992). [cited by applicant]
De Almeida, et al., “Measurement of Melatonin in body fluids: Standards, protocols and procedures”, Childs Nerv. System 27, DOI 10.1007/s00381-010-1278-8, pp. 879-891, (2011). [cited by applicant]
Linder, et al., “Heparin-Binding Protein: An Early Marker of Circulatory Failure in Sepsis”, Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden, CID 2009:49, 8 pages, (Oct. 1,… [cited by applicant]
Matsuyama, et al., “Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating Interleukin-6”, Gut 36, pp. 45-49; (1995). [cited by applicant]
Wei, et al., “A novel sandwich immunosensing method for measuring cardiac troponin 1 in sera”, Analytical Biochemistry 321, pp. 209-216, (2003). [cited by applicant]
Yanez, et al., “Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay”, MDPI, High-Throughput, 6, 18; doi:10.3390/ht6040018, www.mdpi.com/journal/hightroughtput, 12 pages, (2017). [cited by applicant]
Heller, et al., Electrochemical Glucose Sensors and their Applications in Diabetes Management, Chem Review, Department of Chemical Engineering, Univ. of Texas, (Sep. 17, 2007). [cited by applicant]
Merchant, et al., High-Sensitivity Amperometric Biosensors Based on Ferrocene-Modified Linear Poly (ethylenimine), Langmuir Article, 2009 American Chemical Society, (Mar. 24, 2009). [cited by applicant]
Merchant, et al., “Effect of Mediator Spacing on Electrochemical and Enzymatic Response of Ferrocene Redox Polymers”, J. Phys. Chem. 114, pp. 11627-11634, (2010). [cited by applicant]
Xu, et al., Constrution of phospholipid anti-biofouling multilayer on biomedical PET surfaces, Applied Surface Science 255, pp. 538-540, (2008). [cited by applicant]
International Search Report and Written Opinion cited in related Patent Application No. PCT/US2012/067265 mailed Mar. 28, 2013. [cited by applicant]
International Preliminary Report on Patentability received in related Patent Application No. PCT/US2011/063558 dated Jun. 20, 2013. [cited by applicant]
International Preliminary Report on Patentability received in related Patent Application No. PCT/US2012/067265 dated Jun. 12, 2014. [cited by applicant]
International Preliminary Report on Patentability from the International Bureau of WIPO cited in related Application No. PCT/US2020/065384 dated Sep. 9, 2022. [cited by applicant]
Huang, et al. “Catalytic and Inhibitory Kinetic Behavior of Horseradish Peroxidase on the Electrode Surface”, Sensors, 12, 14556-14569 (2012). [cited by applicant]
International Search Report and the Written Opinion from the International Searching Authority in related Application No. PCT/US2020/065384 dated Apr. 19, 2021. [cited by applicant]
Carneiro-da-Cunha, et al., “Physical and thermal properties of a chitosan/alginate naolayered PET film”, Carbohydrate Polymers 82, www.elsevier.com/locate/carbpol, pp. 153-159, (2010). [cited by applicant]
Xu, et al., “Construction of phosopholipid anti-biofouling multilayer on biomedical PET surfaces”, Applied Surface Science 255, www.elsevier.com/locate/apsusc, pp. 538-540, (2008). [cited by applicant]
International Search Report and Written Opinion issued for International Application No. PCT/US2014/027362, dated Sep. 1, 2014, 12 pages. [cited by applicant]
Balabanova, et al., “Detection of Drugs in Sweat” (Nachweis von Drogen im schweib) Institute for Legal Medicine at the University of Ulm, Beitr. Gerichtl. Med. vol. 48, pp. 45-49, (1990). [cited by applicant]